CREBBP and Sepsis: In this study, we show that the inhibitor of CBP prevented sepsis development caused by LPS or CLP, and the combination of ciprofloxacin and SGC-CBP30 had a favorable therapeutic effect on the sepsis model with 80% survival rate.